Legend Biotech Corp (LEGN) Operating cash flow 2018–2025
Legend Biotech Corp (LEGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$100.2MFY2025 · since FY2018: $307.7M → -$100.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$100.2M | +30.4% |
| FY2024 | -$144.0M | +63.4% |
| FY2023 | -$393.3M | -95.4% |
| FY2022 | -$201.3M | -1.4% |
| FY2021 | -$198.5M | +11.0% |
| FY2020 | -$223.0M | -168.5% |
| FY2019 | -$83.1M | -127.0% |
| FY2018 | $307.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice